drug development Related News
Combatting acute pancreatitis with new monoclonal antibody
A phase two global study has confirmed that the investigational drug evinacumab can successfully reduce triglycerides in patients with acute pancreatitis.
The study, led by...
Commonly used anaesthetic may influence Alzheimer’s disease pathology
A novel investigation has indicated that a commonly used anaesthetic may influence brain proteins that stimulate Alzheimer’s disease pathology.
The study, conducted by researchers at...
Study suggests the immune system triggers the effects of psychosis
Novel research has indicated a correlation between genetic changes that influence the brain’s immune system and psychosis, potentially advancing treatments.
The study, conducted by researchers...
World-first major progressive multiple sclerosis trial to launch in UK
The world’s first meg-trial for progressive multiple sclerosis (MS) is to launch later this year in the UK.
The Octopus trial is a revolutionary clinical...
MHRA gives green light to cardiovascular treatment
The Medicines and Healthcare products Regulatory Agency has authorised Vazkepa to reduce cardiovascular risk in statin-treated adult patients who have elevated triglycerides and other...
R21/Matrix-M malaria vaccine becomes first to reach 75% efficacy target
R21/Matrix-M has become the first malaria vaccine ever to achieve the World Health Organization’s 75% efficacy goal after being confirmed by a Phase IIb...
UK to roll out innovative at home COVID-19 treatments
The UK Government is to roll out innovative COVID-19 treatments for patients to use at home in order to mitigate the spread of the...
Chemical biomarker detects severe COVID-19 symptoms
The novel discovery of a chemical biomarker that indicates the severity of COVID-19 symptoms could help to improve patient treatments.
The research, conducted by medical...
Managing early-stage COVID-19 with repurposed drugs
A large-scale human genetic study has been used to identify drug targets that could help manage COVID-19 progression in the early stages of the...
Ribosomes offer the potential for new antibiotics
Researchers are hoping to exploit the processes of ribosomes for the development of novel antibiotic agents.
Ribosomes are an essential component of all living cells,...
Single cell sequencing technology could find drugs that eradicate cancer
Researchers have developed a new sequencing method that could boost international research efforts to find drugs that could eradicate cancer.
The single cell sequencing method,...
Protein kinase inhibitors could offer a new HIV treatment option
A new study shows that protein kinases, enzymes that initiate the process that erodes the body’s immunity, are partly responsible for immunodeficiency in HIV patients. The findings will help explore new treatment options for the condition.
Substance could help develop Alzheimer’s medications
Scientists have confirmed that a common spasmolytic drug can suppress neuroinflammation and could lead to the development of medications against Alzheimer’s Disease.
A team of...
Positive opinion for hereditary angioedema medicine for use in patients over 12
The Committee for Medicinal Products for Human Use (CHMP) has recommended the medicine berotralstat for the routine prophylaxis of hereditary angioedema in patients aged...
New treatment strategy to fight post-transplant infection
Scientists have discovered a potential treatment to protect immunocompromised patients from cytomegalovirus, a serious post-transplant infection.
‘New era’ for multiple sclerosis with £3.7m funding for research
The MS Society has awarded a grant of £3.7m to two UK ‘Centres of Excellence’ as part of its fight to stop multiple sclerosis...
Scientists track how Osmium reacts in single cancer cell
In a major step forward in discovering cancer treatments, scientists at the University of Warwick have tracked how the rare precious metal Osmium reacts in a single cancer cell.
New approach to creating Alzheimer’s drugs helps identify potential treatments
A team of scientists at the University of Sheffield have adopted a new method of creating Alzheimer’s drugs, which has identified two potential new treatments for the disease.
World’s first research and cultivation facility for psychedelic mushrooms
A new partnership will see the world’s first legal research and cultivation facility dedicated exclusively to psilocybin-producing mushrooms and other plant-based psychedelics.
Field Trip Health,...
The case for mass producing psychedelic pharmaceuticals
In this article, financial journalist Marc Davis discusses the mass production of psychedelic pharmaceuticals and the steep educational curve facing medical science.
Medical science is...
